Annual report pursuant to Section 13 and 15(d)

Revenue Information

v3.19.1
Revenue Information
 12 Months Ended
Dec. 31, 2018
Segment Reporting [Abstract]  
Revenue Information

Note 13 – Revenue Information

 

  Revenue by product lines was as follows:

 

    Years Ended  
    December 31,  
Product Line   2018     2017  
MicroParticle Catalyzed Biosensor (“MPC”)   $ 123,941     $ 381,228  
Particle ImmunoFiltration Assay (“PIFA”)     1,422,361       2,232,684  
Rapid Enzymatic Assay (“REA”)     68,750       133,848  
Other     50,518       556,952  
Product Revenue Total     1,665,570       3,304,712  
License Fees     -       50,000  
Total Revenue   $ 1,665,570     $ 3,354,712  

 

The total revenue by geographic area determined based on the location of the customers was as follows:

 

    Years Ended  
    December 31,  
Geographic Region   2018     2017  
United States   $ 1,576,765     $ 2,679,549  
People’s Republic of China     -       502,131  
Rest of World     88,805       173,032  
Total Revenue   $ 1,665,570     $ 3,354,712  

 

The Company had long-lived assets totaling $14,294 and $59,830 located in the People’s Republic of China and $312,573 and $1,305,950 located in the United States as of December 31, 2018 and 2017, respectively.